Search Results | Cancer Research | American Association for Cancer Research

1-20 of 30

Sort by

Sort Order Select

Journal Articles

A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer

Yara Rodríguez, Kenji Unno, Mihai I. Truica, Zachary R. Chalmers, Young A Yoo, Rajita Vatapalli, Vinay Sagar, Jindan Yu, Barbara Lysy, Maha Hussain, Huiying Han, Sarki A. Abdulkadir

Cancer Res canres.3565.2021.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3565

Published: 11 April 2022

View article

Includes: Supplementary data

Journal Articles

Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Shangze Li, Ka-wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Adam Sharp, Wei Yuan, Caterina Aversa, Ximing J. Yang, Peter S. Nelson, Felix Y. Feng, Arul M. Chinnaiyan, Johann S. de Bono, Colm Morrissey, Matthew B. Rettig, Jindan Yu

Cancer Res (2020) 80 (10): 2072.

DOI: https://doi.org/10.1158/0008-5472.CAN-20-0768

Published: 15 May 2020

View article

Journal Articles

Abstract 2099: N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

Adeline Berger, Nicholas Brady, Rohan Bareja, Brian Robinson, Vincenza Conteduca, Michael Augello, Loredana Puca, Adnan Ahmed, Xiaodong Lu, Inah Hwang, Alyssa Bagadion, Andrea Sboner, Olivier Elemento, Jihye Paik, Jindan Yu, Christopher Barbieri, Noah Dephoure, Himisha Beltran, David S. Rickman

Cancer Res (2019) 79 (13_Supplement): 2099.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2099

Published: 01 July 2019

View article

Journal Articles

Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Cancer Res (2019) 79 (10): 2580–2592.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-2812

Published: 15 May 2019

View article

Includes: Supplementary data

Journal Articles

Abstract 4886: Ligand-independent CXCR7 activation of MAPK signaling leads to prostate cancer enzalutamide resistance

Shangze Li, Ka-Wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Jindan Yu

Cancer Res (2018) 78 (13_Supplement): 4886.

DOI: https://doi.org/10.1158/1538-7445.AM2018-4886

Published: 01 July 2018

View article

Journal Articles

Abstract LB-207: A novel role for polycomb group protein BMI1 in prostate cancer

Sen Zhu, Dongyu Zhang, Lin Yan, Weihua Jiang, Qipeng Liu, Rui Wang, Bo Xia, Jonathan C. Zhao, Rong-Fu Wang, Xiaobing Shi, Hung-ming Lam, Xuesen Dong, Jindan Yu, Kaifu Chen, Qi Cao

Cancer Res (2018) 78 (13_Supplement): LB-207.

DOI: https://doi.org/10.1158/1538-7445.AM2018-LB-207

Published: 01 July 2018

View article

Journal Articles

Abstract 1521: Role of Trim28 in prostate cancer

Ka-Wing Fong, Jonathan Zhao, Bin Zheng, Jindan Yu

Cancer Res (2018) 78 (13_Supplement): 1521.

DOI: https://doi.org/10.1158/1538-7445.AM2018-1521

Published: 01 July 2018

View article

Journal Articles

Abstract 1497: A PRC2 independent role of EZH2 in androgen receptor signaling in prostate cancer

Yongik Lee, Jung a Kim, Zhao Changsheng, Xiadong Lu, Ka Wing Fong, Jindan Yu

Cancer Res (2018) 78 (13_Supplement): 1497.

DOI: https://doi.org/10.1158/1538-7445.AM2018-1497

Published: 01 July 2018

View article

Journal Articles

PADI2-Mediated Citrullination Promotes Prostate Cancer Progression

Lin Wang, Guanhua Song, Xiang Zhang, Tingting Feng, Jihong Pan, Weiwen Chen, Muyi Yang, Xinnuo Bai, Yu Pang, Jindan Yu, Jinxiang Han, Bo Han

Cancer Res (2017) 77 (21): 5755–5768.

DOI: https://doi.org/10.1158/0008-5472.CAN-17-0150

Published: 31 October 2017

View article

Includes: Supplementary data

Journal Articles

Abstract 2080: Polycomb-mediated disruption of an AR-feedback loop drives castration-resistant prostate cancer

Ka-Wing Fong, Jonathan Zhao, Jung Kim, Shangze Li, Angela Yang, Bing Song, Laure Rittié, Ming Hu, Ximing Yang, Bernard Perbal, Jindan Yu

Cancer Res (2017) 77 (13_Supplement): 2080.

DOI: https://doi.org/10.1158/1538-7445.AM2017-2080

Published: 01 July 2017

View article

Journal Articles

Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer

Ka-wing Fong, Jonathan C. Zhao, Jung Kim, Shangze Li, Yeqing A. Yang, Bing Song, Laure Rittie, Ming Hu, Ximing Yang, Bernard Perbal, Jindan Yu

Cancer Res (2017) 77 (2): 412–422.

DOI: https://doi.org/10.1158/0008-5472.CAN-16-1949

Published: 16 January 2017

View article

Includes: Supplementary data

Journal Articles

Abstract 1801: FOXA1, a novel regulator of neuroendocrine differentiation

Jung Kim, Hongjian Jin, Jonathan Zhao, Vamsi Parimi, Ximing Yang, Jindan Yu

Cancer Res (2016) 76 (14_Supplement): 1801.

DOI: https://doi.org/10.1158/1538-7445.AM2016-1801

Published: 15 July 2016

View article

Journal Articles

ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer

Longtao Wu, Jonathan C. Zhao, Jung Kim, Hong-Jian Jin, Cun-Yu Wang, Jindan Yu

Cancer Res (2013) 73 (19): 6068–6079.

DOI: https://doi.org/10.1158/0008-5472.CAN-13-0882

Published: 01 October 2013

View article

Includes: Supplementary data

Journal Articles

Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis

Hong-Jian Jin, Jonathan C. Zhao, Irene Ogden, Raymond C. Bergan, Jindan Yu

Cancer Res (2013) 73 (12): 3725–3736.

DOI: https://doi.org/10.1158/0008-5472.CAN-12-3468

Published: 13 June 2013

View article

Includes: Supplementary data

Journal Articles

Abstract IA19: Cooperation between androgen receptor and Polycomb in prostate cancer

Jonathan C. Zhao, Christine Runkle, Jianjun Yu, Longtao Wu, Hongjian Jin, Timothy Kuzel, Chung Lee, Jindan Yu

Cancer Res (2012) 72 (4_Supplement): IA19.

DOI: https://doi.org/10.1158/1538-7445.PRCA2012-IA19

Published: 09 May 2013

View article

Journal Articles

Abstract 3077: TMPRSS2-ERG regulation of miRNA in prostate cancer.

Jung Kim, Longtao Wu, Hong-Jian Jin, Jonathan Zhao, Jindan Yu

Cancer Res (2013) 73 (8_Supplement): 3077.

DOI: https://doi.org/10.1158/1538-7445.AM2013-3077

Published: 15 April 2013

View article

Journal Articles

Abstract LB-273: Transcriptional regulation by androgen receptor in prostate cancer

Jonathan Zhao, Christine Runkle, Longtao Wu, Hong-Jian Jin, Jindan Yu

Cancer Res (2012) 72 (8_Supplement): LB-273.

DOI: https://doi.org/10.1158/1538-7445.AM2012-LB-273

Published: 15 April 2012

View article

Journal Articles

Definition of a FoxA1 Cistrome That Is Crucial for G₁ to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer

Chunpeng Zhang, Liguo Wang, Dayong Wu, Hongyan Chen, Zhong Chen, Jennifer M. Thomas-Ahner, Debra L. Zynger, Jérôme Eeckhoute, Jindan Yu, Jun Luo, Myles Brown, Steven K. Clinton, Kenneth P. Nephew, Tim H.-M. Huang, Wei Li, Qianben Wang

Cancer Res (2011) 71 (21): 6738–6748.

DOI: https://doi.org/10.1158/0008-5472.CAN-11-1882

Published: 30 October 2011

View article

Includes: Supplementary data

Journal Articles

Abstract 2155: The origins and functional consequences of ETS gene fusions in prostate cancer

Ram S. Mani, Scott A. Tomlins, Chad J. Brenner, Lei Wang, Matthew Iyer, Jindan Yu, Qi Cao, Kaitlin Callahan, Aparna Ghosh, Mukesh K. Nyati, Sooryanarayana Varambally, Nallasivam Palanisamy, Arul M. Chinnaiyan

Cancer Res (2011) 71 (8_Supplement): 2155.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2155

Published: 15 April 2011

View article

Journal Articles

Abstract 2795: An onco-protein axis linking polycomb repressive complex 2 and polycomb repressive complex 1 through miRNAs in cancer

Cancer Res (2011) 71 (8_Supplement): 2795.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2795

Published: 15 April 2011

View article

NARROW

A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer

Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Abstract 2099: N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Abstract 4886: Ligand-independent CXCR7 activation of MAPK signaling leads to prostate cancer enzalutamide resistance

Abstract LB-207: A novel role for polycomb group protein BMI1 in prostate cancer

Abstract 1521: Role of Trim28 in prostate cancer

Abstract 1497: A PRC2 independent role of EZH2 in androgen receptor signaling in prostate cancer

PADI2-Mediated Citrullination Promotes Prostate Cancer Progression

Abstract 2080: Polycomb-mediated disruption of an AR-feedback loop drives castration-resistant prostate cancer

Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer

Abstract 1801: FOXA1, a novel regulator of neuroendocrine differentiation

ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer

Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis

Abstract IA19: Cooperation between androgen receptor and Polycomb in prostate cancer

Abstract 3077: TMPRSS2-ERG regulation of miRNA in prostate cancer.

Abstract LB-273: Transcriptional regulation by androgen receptor in prostate cancer

Definition of a FoxA1 Cistrome That Is Crucial for G₁ to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer

Abstract 2155: The origins and functional consequences of ETS gene fusions in prostate cancer

Abstract 2795: An onco-protein axis linking polycomb repressive complex 2 and polycomb repressive complex 1 through miRNAs in cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only